Wells Fargo’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39K | Buy |
3,458
+31
| +0.9% | +$349 | ﹤0.01% | 5172 |
|
|
2025
Q1 | $34.6K | Sell |
3,427
-4,074
| -54% | -$41.1K | ﹤0.01% | 5063 |
|
|
2024
Q4 | $88.7K | Buy |
7,501
+3,426
| +84% | +$40.5K | ﹤0.01% | 4775 |
|
|
2024
Q3 | $47K | Buy |
4,075
+1,048
| +35% | +$12.1K | ﹤0.01% | 4966 |
|
|
2024
Q2 | $32K | Sell |
3,027
-13,625
| -82% | -$144K | ﹤0.01% | 5075 |
|
|
2024
Q1 | $176K | Sell |
16,652
-9,417
| -36% | -$99.3K | ﹤0.01% | 4189 |
|
|
2023
Q4 | $293K | Sell |
26,069
-125,465
| -83% | -$1.41M | ﹤0.01% | 3858 |
|
|
2023
Q3 | $1.77M | Buy |
151,534
+12,402
| +9% | +$145K | ﹤0.01% | 2690 |
|
|
2023
Q2 | $1.4M | Buy |
139,132
+12,807
| +10% | +$129K | ﹤0.01% | 3023 |
|
|
2023
Q1 | $932K | Buy |
126,325
+125,588
| +17,040% | +$927K | ﹤0.01% | 3206 |
|
|
2022
Q4 | $5.89K | Buy |
737
+37
| +5% | +$296 | ﹤0.01% | 5396 |
|
|
2022
Q3 | $2K | Buy |
700
+52
| +8% | +$149 | ﹤0.01% | 5857 |
|
|
2022
Q2 | $3K | Buy |
648
+52
| +9% | +$241 | ﹤0.01% | 5916 |
|
|
2022
Q1 | $3K | Buy |
596
+8
| +1% | +$40 | ﹤0.01% | 6237 |
|
|
2021
Q4 | $6K | Buy |
+588
| New | +$6K | ﹤0.01% | 6125 |
|